文献速递眼底病与葡萄膜炎

亚洲2型糖尿病患者中感知的糖尿病自我管理障碍与糖尿病视网膜病变的关联

Association Between Perceived Barriers to Diabetes Self-management and Diabetic Retinopathy in Asian Patients With Type 2 Diabetes.
PubMed 文献 · JAMA Ophthalmol · 2017-01-01

新加坡糖尿病管理项目横断面研究纳入361例2型糖尿病患者,用Rasch分析优化的23条目问卷评估感知的糖尿病自我管理障碍,并按改良Airlie House分级从2视野眼底图分级糖尿病视网膜病变。感知障碍程度越高,任何糖尿病视网膜病变、轻中度及重度病变的比值比均升高,且独立于血糖、血压、血脂控制、视力与社会经济指标。

要点

  • 感知障碍评分每增加一个单位,任何糖尿病视网膜病变的比值比为1.32(95%CI 1.06-1.66)。
  • 轻中度病变比值比1.30(95%CI 1.01-1.68),重度病变比值比1.36(95%CI 1.03-1.79)。
  • 该关联独立于糖化血红蛋白、血压、血脂、呈现视力及社会经济指标。

核心结论

  • 更大的感知糖尿病自我管理障碍与糖尿病视网膜病变严重程度独立相关。
  • 作者认为,减少患者、医生及系统层面糖尿病照护障碍的循证干预可能有助于降低糖尿病视网膜病变风险,但需要纵向数据。

研究设计与样本

  • 新加坡糖尿病管理项目为横断面诊所研究,2010年12月28日至2013年3月20日在新加坡国家眼科中心开展。
  • 排除1型糖尿病及眼底图像不可分级者后,共361例参与者纳入分析。
  • 统计分析于2017年7月20日至9月8日进行。
  • 感知障碍用含23条目的问卷评估,涵盖糖尿病自我管理知识、照护可及性及对卫生专业人员的信心,采用Rasch分析优化量表心理测量学特性,评分越低表示自感障碍程度越高。
  • 糖尿病视网膜病变按改良Airlie House分级系统从2视野视网膜图像分级:无病变(早期治疗糖尿病视网膜病变研究分级10-15;n=154)、轻中度(分级20-43;n=112)、重度(分级≥53和/或存在临床显著黄斑水肿;n=95)。

主要发现

  • 361例参与者中女性105例、男性256例,平均(SD)年龄57(8)岁。
  • 感知障碍程度更大者,任何糖尿病视网膜病变的比值比为1.32(95%CI 1.06-1.66)。
  • 轻中度糖尿病视网膜病变的比值比为1.30(95%CI 1.01-1.68)。
  • 重度糖尿病视网膜病变的比值比为1.36(95%CI 1.03-1.79)。
  • 该关联独立于糖尿病控制(糖化血红蛋白、血压、血脂水平)、呈现视力及社会经济指标。

临床怎么用

  • 作者认为,减少患者、医生及系统层面糖尿病照护障碍的循证干预可能有助于降低糖尿病视网膜病变风险,同时指出需要纵向数据。

局限性

  • 原文指出需要纵向数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: A patient’s perceived barriers to diabetes self-management (DSM) may affect his or her risk of diabetic retinopathy (DR); however, few studies have examined this association. OBJECTIVE: To examine the association between perceived barriers to DSM and the severity spectrum of DR in Asian patients with type 2 diabetes. DESIGN, SETTING, AND PARTICIPANTS: A cross-sectional clinic-based study, the Singapore Diabetes Management Project, was conducted from December 28, 2010, to March 20, 2013, at the Singapore National Eye Centre, a tertiary eye care institute. After excluding patients with type 1 diabetes and ungradable fundus images, 361 participants were included in the analyses. Statistical analysis was conducted from July 20 to September 8, 2017. EXPOSURE: The degree of perceived barriers to DSM was assessed using a 23-item questionnaire comprising items about knowledge of DSM, access to care, and confidence in health care professionals. Rasch analysis was used to optimize the scale’s psychometric properties, with lower scores indicating a higher degree of self-perceived barriers. MAIN OUTCOMES AND MEASURES: Diabetic retinopathy was graded from 2-field retinal images into categories of no DR (Early Treatment Diabetic Retinopathy Study levels 10-15; n = 154), mild to moderate DR (levels 20-43; n = 112), and severe DR (levels ≥53 and/or presence of clinically significant macular edema; n = 95) using the modified Airlie House classification system of DR. Multinomial logistic regression models were used to assess the association between perceived barriers and severity of DR in the worse-affected eye. RESULTS: Among the 361 participants (105 women and 256 men; mean [SD] age, 57 [8] years), a greater magnitude of perceived barriers to DSM was independently associated with higher odds of having any DR (odds ratio, 1.32; 95% CI, 1.06-1.66), mild to moderate DR (odds ratio, 1.30; 95% CI, 1.01-1.68), and severe DR (odds ratio, 1.36; 95% CI, 1.03-1.79). This association was independent of diabetes control (hemoglobin A1c, blood pressure, and lipid levels), presenting visual acuity, and socioeconomic indicators. CONCLUSIONS AND RELEVANCE: These results suggest that greater perceived barriers to DSM are independently associated with severity of DR. Although longitudinal data are needed, these findings suggest that evidence-based interventions to reduce patient-, practitioner-, and system-related barriers to diabetes care may help reduce the risk of DR.

来源:JAMA Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Man REK, Fenwick EK, Gan ATL, et al. Association Between Perceived Barriers to Diabetes Self-management and Diabetic Retinopathy in Asian Patients With Type 2 Diabetes. JAMA Ophthalmol. 2017. PMID: 29145552. doi:10.1001/jamaophthalmol.2017.4888

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。